SARS-CoV-2 transmission in intercollegiate athletics not fully mitigated with daily antigen testing.
Journal
medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986
Informations de publication
Date de publication:
06 Mar 2021
06 Mar 2021
Historique:
entrez:
10
3
2021
pubmed:
11
3
2021
medline:
11
3
2021
Statut:
epublish
Résumé
High frequency, rapid turnaround SARS-CoV-2 testing continues to be proposed as a way of efficiently identifying and mitigating transmission in congregate settings. However, two SARS-CoV-2 outbreaks occurred among intercollegiate university athletic programs during the fall 2020 semester despite mandatory directly observed daily antigen testing. During the fall 2020 semester, athletes and staff in both programs were tested daily using Quidel's Sofia SARS Antigen Fluorescent Immunoassay (FIA), with positive antigen results requiring confirmatory testing with real-time reverse transcription polymerase chain reaction (RT-PCR). We used genomic sequencing to investigate transmission dynamics in these two outbreaks. In Outbreak 1, 32 confirmed cases occurred within a university athletics program after the index patient attended a meeting while infectious despite a negative antigen test on the day of the meeting. Among isolates sequenced from Outbreak 1, 24 (92%) of 26 were closely related, suggesting sustained transmission following an initial introduction event. In Outbreak 2, 12 confirmed cases occurred among athletes from two university programs that faced each other in an athletic competition despite receiving negative antigen test results on the day of the competition. Sequences from both teams were closely related and unique from strains circulating in the community, suggesting transmission during intercollegiate competition. These findings suggest that antigen testing alone, even when mandated and directly observed, may not be sufficient as an intervention to prevent SARS-CoV-2 outbreaks in congregate settings, and highlights the importance of supplementing serial antigen testing with appropriate mitigation strategies to prevent SARS-CoV-2 outbreak in congregate settings. High frequency, rapid turnaround SARS-CoV-2 testing continues to be proposed as a way of efficiently identifying and mitigating transmission in congregate settings. However, here we describe two SARS-CoV-2 outbreaks occurred among intercollegiate university athletic programs during the fall 2020 semester.
Sections du résumé
BACKGROUND
BACKGROUND
High frequency, rapid turnaround SARS-CoV-2 testing continues to be proposed as a way of efficiently identifying and mitigating transmission in congregate settings. However, two SARS-CoV-2 outbreaks occurred among intercollegiate university athletic programs during the fall 2020 semester despite mandatory directly observed daily antigen testing.
METHODS
METHODS
During the fall 2020 semester, athletes and staff in both programs were tested daily using Quidel's Sofia SARS Antigen Fluorescent Immunoassay (FIA), with positive antigen results requiring confirmatory testing with real-time reverse transcription polymerase chain reaction (RT-PCR). We used genomic sequencing to investigate transmission dynamics in these two outbreaks.
RESULTS
RESULTS
In Outbreak 1, 32 confirmed cases occurred within a university athletics program after the index patient attended a meeting while infectious despite a negative antigen test on the day of the meeting. Among isolates sequenced from Outbreak 1, 24 (92%) of 26 were closely related, suggesting sustained transmission following an initial introduction event. In Outbreak 2, 12 confirmed cases occurred among athletes from two university programs that faced each other in an athletic competition despite receiving negative antigen test results on the day of the competition. Sequences from both teams were closely related and unique from strains circulating in the community, suggesting transmission during intercollegiate competition.
CONCLUSIONS
CONCLUSIONS
These findings suggest that antigen testing alone, even when mandated and directly observed, may not be sufficient as an intervention to prevent SARS-CoV-2 outbreaks in congregate settings, and highlights the importance of supplementing serial antigen testing with appropriate mitigation strategies to prevent SARS-CoV-2 outbreak in congregate settings.
SUMMARY
CONCLUSIONS
High frequency, rapid turnaround SARS-CoV-2 testing continues to be proposed as a way of efficiently identifying and mitigating transmission in congregate settings. However, here we describe two SARS-CoV-2 outbreaks occurred among intercollegiate university athletic programs during the fall 2020 semester.
Identifiants
pubmed: 33688665
doi: 10.1101/2021.03.03.21252838
pmc: PMC7941640
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NLM NIH HHS
ID : T15 LM007359
Pays : United States
Commentaires et corrections
Type : UpdateIn
Références
MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70(3):100-105
pubmed: 33476316
J Clin Virol. 2021 Feb;135:104713
pubmed: 33352470
CMAJ Open. 2020 Dec 8;8(4):E819-E824
pubmed: 33293331
J Clin Virol. 2020 Aug;129:104500
pubmed: 32585619
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):130-135
pubmed: 33507889
Disaster Med Public Health Prep. 2020 Sep 10;:1-5
pubmed: 32907679
MMWR Morb Mortal Wkly Rep. 2020 Dec 11;69(49):1860-1867
pubmed: 33301434
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):114-117
pubmed: 33507887
N Engl J Med. 2021 Jan 21;384(3):197-199
pubmed: 33472283
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):446-450
pubmed: 32298246
J Clin Microbiol. 2020 Dec 17;59(1):
pubmed: 33023911
Int J Infect Dis. 2020 Oct;99:328-333
pubmed: 32497809
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):141-143
pubmed: 33507895
Clin Infect Dis. 2020 Dec 31;71(11):2920-2926
pubmed: 32548628
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
Nat Protoc. 2017 Jun;12(6):1261-1276
pubmed: 28538739
MMWR Morb Mortal Wkly Rep. 2021 Jan 01;69(5152):1642-1647
pubmed: 33382679
PLoS Pathog. 2021 Feb 26;17(2):e1009373
pubmed: 33635912
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Sci Transl Med. 2020 Dec 9;12(573):
pubmed: 33229462
Nat Commun. 2020 Nov 3;11(1):5558
pubmed: 33144575